Open label phase II clinical trial of orteronel (TAK-700) in metastatic or advanced non-resectable granulosa cell ovarian tumors: The Greko II study—GETHI 2013-01.
2015 ◽
Vol 33
(15_suppl)
◽
pp. TPS5612-TPS5612
Keyword(s):
Phase Ii
◽